US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 12, 2019 (7 years ago)

S-Hyaluronidase 150u/Ml Inj Soln

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

S-HYALURONIDASE 150U/ML INJ SOLN (PF), 5 ML vial, Red Mountain Compounding RX

Recalling firm
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0227-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hyaluronidase recalls

See all
Class II · Moderate risk Terminated

Hylenex recombinant

Reason cGMP Deviations: Temperature excursion

Mckesson Medical-Surgical Inc. Corporate Office NDC 18657-117-04 D-0116-2025
Class II · Moderate risk Terminated

Lidocaine HCL / Bupivacaine HCL

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1548-18 D-0404-2022
Class II · Moderate risk Terminated

LIDOcaine 2%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0071-2020
Class II · Moderate risk Terminated

Hyaluronidase

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0060-2020